pI: 8.4558 |
Length (AA): 471 |
MW (Da): 54286 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 1
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
46 | 444 | 1pfz (A) | 86 | 329 | 24.00 | 0 | 1 | 0.924534 | 0.27 |
58 | 437 | 1miq (A) | 99 | 322 | 30.00 | 0 | 1 | 1.05599 | -0.05 |
88 | 334 | 1b5f (A) | 6 | 224 | 30.00 | 0.0000000072 | 1 | 0.691616 | 0.07 |
94 | 439 | 4aa9 (A) | 14 | 321 | 31.00 | 0 | 1 | 0.961807 | -0.53 |
96 | 176 | 4od9 (A) | 15 | 92 | 42.00 | 0.0000075 | 0.41 | 0.488175 | 0.39 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Gametocyte, 4 hs Ring, 22 hs Schizont, Male gametocyte. | Otto TD Yeoh LM |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | Ookinete, Female gametocyte. | Otto TD Yeoh LM |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 0-20% percentile | 16 hs Trophozoite, Erthyrocytic stages. | Otto TD Yeoh LM |
Yeoh LM | Comparative transcriptomics of female and male gametocytes in Plasmodium berghei and the evolution of sex in alveolates. |
Otto TD | A comprehensive evaluation of rodent malaria parasite genomes and gene expression. |
Ortholog group members (OG5_145118)
Species | Accession | Gene Product |
---|---|---|
Babesia bovis | BBOV_IV009660 | aspartyl protease, putative |
Neospora caninum | NCLIV_034810 | eukaryotic aspartyl protease, putative |
Plasmodium berghei | PBANKA_0517600 | plasmepsin VII |
Plasmodium falciparum | PF3D7_1033800 | plasmepsin VII |
Plasmodium knowlesi | PKNH_0618600 | aspartyl protease, putative |
Plasmodium vivax | PVX_111035 | aspartyl protease, putative |
Plasmodium yoelii | PY00469 | Eukaryotic aspartyl protease |
Toxoplasma gondii | TGME49_272510 | aspartyl protease |
Theileria parva | TP01_0802 | hypothetical protein |
Theileria parva | TP01_0803 | hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
PBANKA_0517600 this record | Plasmodium berghei | Dispensable | plasmo |
TGME49_272510 | Toxoplasma gondii | Probably non-essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Bos taurus | Cathepsin D | 390 aa | 26.0% | 377 aa | Compounds | References |
Macaca mulatta | Renin | 406 aa | 26.3% | 365 aa | Compounds | References |
Callithrix jacchus | Renin | 400 aa | 26.0% | 389 aa | Compounds | References |
Sus scrofa | Pepsin A | 385 aa | 28.5% | 410 aa | Compounds | References |
Penicillium janthinellum | Penicillopepsin | 323 aa | 21.6% | 347 aa | Compounds | References |
Plasmodium falciparum | plasmepsin II | 453 aa | 25.1% | 406 aa | Compounds | References |
Rattus norvegicus | Renin | 402 aa | 27.2% | 360 aa | Compounds | References |
Schistosoma mansoni | cathepsin D (A01 family) | 430 aa | 25.8% | 360 aa | Compounds | References |
Schistosoma mansoni | cathepsin D (A01 family) | 428 aa | 25.8% | 360 aa | Compounds | References |
Macaca fascicularis | Renin | 406 aa | 26.2% | 367 aa | Compounds | References |
Rhizopus microsporus var. chinensis | Rhizopuspepsin | 393 aa | 24.1% | 349 aa | Compounds | References |
Oryctolagus cuniculus | Renin | 280 aa | 24.9% | 325 aa | Compounds | References |
Rattus norvegicus | Pepsinogen C | 392 aa | 27.3% | 366 aa | Compounds | References |